| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.977 | 0.004 | 0.982 | Antiinflammatory | 0.982 0.004 DB00860 0.977 0.004 DBMET02848 0.96 0.004 DBMET02849 0.96 0.004 DBMET02850 0.98 0.004 DBMET02851 0.98 0.004 DBMET02853 0.98 0.004 DB00635 0.956 0.004 DBMET02852 0.956 0.004 DBMET02854 0.976 0.004 DBMET02856 0.956 0.004 DBMET02857 0.975 0.004 DBMET02859 0.951 0.004 DBMET02860 0.951 0.004 DBMET02861 0.976 0.004 DBMET02863 0.976 0.004 DBMET02864 0.941 0.005 DBMET02855 0.941 0.005 DBMET02858 0.908 0.005 DBMET02862 | DB00860 | |
| 0.964 | 0.002 | 0.964 | Hypoxia-inducible factor 1 alpha inhibitor | 0.95 0.002 DB00860 0.904 0.002 DBMET02848 0.81 0.003 DBMET02849 0.81 0.003 DBMET02850 0.859 0.003 DBMET02851 0.859 0.003 DBMET02853 0.901 0.002 DB00635 0.73 0.004 DBMET02852 0.73 0.004 DBMET02854 0.817 0.003 DBMET02856 0.73 0.004 DBMET02857 0.851 0.003 DBMET02859 0.767 0.004 DBMET02860 0.767 0.004 DBMET02861 0.827 0.003 DBMET02863 0.827 0.003 DBMET02864 0.687 0.005 DBMET02855 0.687 0.005 DBMET02858 0.657 0.005 DBMET02862 | ||
| 0.928 | 0.004 | 0.931 | Transcription factor NF kappa B inhibitor | 0.922 0.004 DB00860 0.881 0.008 DBMET02848 0.853 0.01 DBMET02849 0.853 0.01 DBMET02850 0.915 0.005 DBMET02851 0.915 0.005 DBMET02853 0.898 0.006 DB00635 0.832 0.011 DBMET02852 0.832 0.011 DBMET02854 0.931 0.004 DBMET02856 0.832 0.011 DBMET02857 0.833 0.011 DBMET02859 0.796 0.013 DBMET02860 0.796 0.013 DBMET02861 0.907 0.005 DBMET02863 0.907 0.005 DBMET02864 0.873 0.008 DBMET02855 0.873 0.008 DBMET02858 0.789 0.014 DBMET02862 | DBMET02856 | |
| 0.911 | 0.002 | 0.911 | Antipruritic | 0.904 0.002 DB00860 0.879 0.002 DBMET02848 0.683 0.003 DBMET02849 0.683 0.003 DBMET02850 0.804 0.002 DBMET02851 0.804 0.002 DBMET02853 0.842 0.002 DB00635 0.461 0.005 DBMET02852 0.461 0.005 DBMET02854 0.741 0.003 DBMET02856 0.461 0.005 DBMET02857 0.811 0.002 DBMET02859 0.542 0.004 DBMET02860 0.542 0.004 DBMET02861 0.72 0.003 DBMET02863 0.72 0.003 DBMET02864 0.377 0.008 DBMET02855 0.377 0.008 DBMET02858 0.316 0.012 DBMET02862 | ||
| 0.873 | 0.002 | 0.968 | Androgen antagonist | 0.968 0.001 DB00860 0.956 0.002 DBMET02848 0.806 0.002 DBMET02849 0.806 0.002 DBMET02850 0.829 0.002 DBMET02851 0.829 0.002 DBMET02853 0.902 0.002 DB00635 0.577 0.003 DBMET02852 0.577 0.003 DBMET02854 0.928 0.002 DBMET02856 0.577 0.003 DBMET02857 0.872 0.002 DBMET02859 0.68 0.003 DBMET02860 0.68 0.003 DBMET02861 0.744 0.002 DBMET02863 0.744 0.002 DBMET02864 0.708 0.003 DBMET02855 0.708 0.003 DBMET02858 0.695 0.003 DBMET02862 | DB00860 | |
| 0.863 | 0 | 0.899 | Transcortin receptor antagonist | 0.899 0 DB00860 0.611 0 DBMET02848 0.367 0 DBMET02849 0.367 0 DBMET02850 0.824 0 DBMET02851 0.824 0 DBMET02853 0.84 0 DB00635 0.184 0 DBMET02852 0.184 0 DBMET02854 0.791 0 DBMET02856 0.184 0 DBMET02857 0.368 0 DBMET02859 0.246 0 DBMET02860 0.246 0 DBMET02861 0.824 0 DBMET02863 0.824 0 DBMET02864 0.137 0 DBMET02855 0.137 0 DBMET02858 0.103 0 DBMET02862 | DB00860 | |
| 0.836 | 0.005 | 0.89 | Toll-Like receptor 7 agonist | 0.89 0.004 DB00860 0.881 0.005 DBMET02848 0.864 0.005 DBMET02849 0.864 0.005 DBMET02850 0.878 0.005 DBMET02851 0.878 0.005 DBMET02853 0.841 0.005 DB00635 0.85 0.005 DBMET02852 0.85 0.005 DBMET02854 0.821 0.005 DBMET02856 0.85 0.005 DBMET02857 0.828 0.005 DBMET02859 0.793 0.005 DBMET02860 0.793 0.005 DBMET02861 0.816 0.005 DBMET02863 0.816 0.005 DBMET02864 0.77 0.005 DBMET02855 0.77 0.005 DBMET02858 0.592 0.018 DBMET02862 | DB00860 | |
| 0.834 | 0.005 | 0.888 | Toll-Like receptor agonist | 0.888 0.004 DB00860 0.878 0.005 DBMET02848 0.865 0.005 DBMET02849 0.865 0.005 DBMET02850 0.876 0.005 DBMET02851 0.876 0.005 DBMET02853 0.838 0.005 DB00635 0.85 0.005 DBMET02852 0.85 0.005 DBMET02854 0.815 0.005 DBMET02856 0.85 0.005 DBMET02857 0.824 0.005 DBMET02859 0.794 0.005 DBMET02860 0.794 0.005 DBMET02861 0.811 0.005 DBMET02863 0.811 0.005 DBMET02864 0.769 0.005 DBMET02855 0.769 0.005 DBMET02858 0.596 0.018 DBMET02862 | DB00860 | |
| 0.791 | 0.001 | 0.879 | Androgen agonist | 0.879 0.001 DB00860 0.8 0.001 DBMET02848 0.855 0.001 DBMET02849 0.855 0.001 DBMET02850 0.672 0.001 DBMET02851 0.672 0.001 DBMET02853 0.774 0.001 DB00635 0.632 0.001 DBMET02852 0.632 0.001 DBMET02854 0.803 0.001 DBMET02856 0.632 0.001 DBMET02857 0.671 0.001 DBMET02859 0.765 0.001 DBMET02860 0.765 0.001 DBMET02861 0.669 0.001 DBMET02863 0.669 0.001 DBMET02864 0.768 0.001 DBMET02855 0.768 0.001 DBMET02858 0.767 0.001 DBMET02862 | DB00860 | |
| 0.752 | 0.001 | 0.79 | Glucocorticoid agonist | 0.79 0.001 DB00860 0.765 0.001 DBMET02848 0.587 0.001 DBMET02849 0.587 0.001 DBMET02850 0.765 0.001 DBMET02851 0.765 0.001 DBMET02853 0.767 0.001 DB00635 0.472 0.001 DBMET02852 0.472 0.001 DBMET02854 0.748 0.001 DBMET02856 0.472 0.001 DBMET02857 0.729 0.001 DBMET02859 0.429 0.001 DBMET02860 0.429 0.001 DBMET02861 0.702 0.001 DBMET02863 0.702 0.001 DBMET02864 0.396 0.001 DBMET02855 0.396 0.001 DBMET02858 0.26 0.002 DBMET02862 | DB00860 | |
| 0.751 | 0.004 | 0.773 | Immunosuppressant | 0.77 0.004 DB00860 0.756 0.004 DBMET02848 0.773 0.004 DBMET02849 0.773 0.004 DBMET02850 0.76 0.004 DBMET02851 0.76 0.004 DBMET02853 0.739 0.004 DB00635 0.764 0.004 DBMET02852 0.764 0.004 DBMET02854 0.732 0.004 DBMET02856 0.764 0.004 DBMET02857 0.724 0.005 DBMET02859 0.742 0.004 DBMET02860 0.742 0.004 DBMET02861 0.727 0.005 DBMET02863 0.727 0.005 DBMET02864 0.737 0.004 DBMET02855 0.737 0.004 DBMET02858 0.711 0.005 DBMET02862 | DBMET02850 | |
| 0.753 | 0.023 | 0.802 | Apoptosis agonist | 0.768 0.02 DB00860 0.737 0.025 DBMET02848 0.699 0.031 DBMET02849 0.699 0.031 DBMET02850 0.743 0.024 DBMET02851 0.743 0.024 DBMET02853 0.775 0.02 DB00635 0.671 0.035 DBMET02852 0.671 0.035 DBMET02854 0.802 0.016 DBMET02856 0.671 0.035 DBMET02857 0.743 0.024 DBMET02859 0.699 0.031 DBMET02860 0.699 0.031 DBMET02861 0.749 0.023 DBMET02863 0.749 0.023 DBMET02864 0.733 0.025 DBMET02855 0.733 0.025 DBMET02858 0.714 0.028 DBMET02862 | DBMET02856 | |
| 0.729 | 0.002 | 0.879 | Aromatase inhibitor | 0.761 0.002 DB00860 0.752 0.002 DBMET02848 0.465 0.004 DBMET02849 0.465 0.004 DBMET02850 0.8 0.002 DBMET02851 0.8 0.002 DBMET02853 0.828 0.001 DB00635 0.518 0.003 DBMET02852 0.518 0.003 DBMET02854 0.658 0.002 DBMET02856 0.518 0.003 DBMET02857 0.82 0.002 DBMET02859 0.561 0.003 DBMET02860 0.561 0.003 DBMET02861 0.879 0.001 DBMET02863 0.879 0.001 DBMET02864 0.325 0.005 DBMET02855 0.325 0.005 DBMET02858 0.477 0.003 DBMET02862 | DBMET02864 | |
| 0.691 | 0.001 | 0.719 | Lipocortins synthesis antagonist | 0.715 0.001 DB00860 0.719 0.001 DBMET02848 0.702 0.001 DBMET02849 0.702 0.001 DBMET02850 0.689 0.001 DBMET02851 0.689 0.001 DBMET02853 0.621 0.002 DB00635 0.677 0.001 DBMET02852 0.677 0.001 DBMET02854 0.674 0.001 DBMET02856 0.677 0.001 DBMET02857 0.629 0.002 DBMET02859 0.605 0.002 DBMET02860 0.605 0.002 DBMET02861 0.587 0.002 DBMET02863 0.587 0.002 DBMET02864 0.662 0.001 DBMET02855 0.662 0.001 DBMET02858 0.564 0.003 DBMET02862 | DBMET02848 | |
| 0.645 | 0.002 | 0.678 | Interferon gamma antagonist | 0.678 0.001 DB00860 0.636 0.002 DBMET02848 0.617 0.002 DBMET02849 0.617 0.002 DBMET02850 0.63 0.002 DBMET02851 0.63 0.002 DBMET02853 0.657 0.001 DB00635 0.568 0.003 DBMET02852 0.568 0.003 DBMET02854 0.641 0.002 DBMET02856 0.568 0.003 DBMET02857 0.616 0.002 DBMET02859 0.602 0.002 DBMET02860 0.602 0.002 DBMET02861 0.633 0.002 DBMET02863 0.633 0.002 DBMET02864 0.58 0.003 DBMET02855 0.58 0.003 DBMET02858 0.579 0.003 DBMET02862 | DB00860 | |
| 0.64 | 0 | 0.64 | Arachidonic acid antagonist | 0.509 0 DB00860 0.43 0 DBMET02848 0.376 0.001 DBMET02849 0.376 0.001 DBMET02850 0.445 0 DBMET02851 0.445 0 DBMET02853 0.461 0 DB00635 0.346 0.001 DBMET02852 0.346 0.001 DBMET02854 0.429 0 DBMET02856 0.346 0.001 DBMET02857 0.398 0 DBMET02859 0.359 0.001 DBMET02860 0.359 0.001 DBMET02861 0.442 0 DBMET02863 0.442 0 DBMET02864 0.337 0.001 DBMET02855 0.337 0.001 DBMET02858 0.335 0.001 DBMET02862 | ||
| 0.626 | 0.002 | 0.751 | Progesterone antagonist | 0.745 0.001 DB00860 0.751 0.001 DBMET02848 0.482 0.002 DBMET02849 0.482 0.002 DBMET02850 0.656 0.002 DBMET02851 0.656 0.002 DBMET02853 0.52 0.002 DB00635 0.368 0.003 DBMET02852 0.368 0.003 DBMET02854 0.55 0.002 DBMET02856 0.368 0.003 DBMET02857 0.53 0.002 DBMET02859 0.26 0.004 DBMET02860 0.26 0.004 DBMET02861 0.39 0.003 DBMET02863 0.39 0.003 DBMET02864 0.279 0.004 DBMET02855 0.279 0.004 DBMET02858 0.176 0.005 DBMET02862 | DBMET02848 | |
| 0.615 | 0.017 | 0.73 | Aldehyde oxidase inhibitor | 0.726 0.006 DB00860 0.599 0.019 DBMET02848 0.687 0.009 DBMET02849 0.687 0.009 DBMET02850 0.635 0.014 DBMET02851 0.635 0.014 DBMET02853 0.73 0.006 DB00635 0.59 0.02 DBMET02852 0.59 0.02 DBMET02854 0.513 0.031 DBMET02856 0.59 0.02 DBMET02857 0.604 0.018 DBMET02859 0.701 0.008 DBMET02860 0.701 0.008 DBMET02861 0.635 0.014 DBMET02863 0.635 0.014 DBMET02864 0.436 0.042 DBMET02855 0.436 0.042 DBMET02858 0.537 0.028 DBMET02862 | DB00635 | |
| 0.6 | 0.005 | 0.746 | Diuretic | 0.732 0.004 DB00860 0.72 0.004 DBMET02848 0.746 0.003 DBMET02849 0.746 0.003 DBMET02850 0.639 0.004 DBMET02851 0.639 0.004 DBMET02853 0.56 0.005 DB00635 0.661 0.004 DBMET02852 0.661 0.004 DBMET02854 0.553 0.005 DBMET02856 0.661 0.004 DBMET02857 0.542 0.006 DBMET02859 0.584 0.005 DBMET02860 0.584 0.005 DBMET02861 0.428 0.011 DBMET02863 0.428 0.011 DBMET02864 0.575 0.005 DBMET02855 0.575 0.005 DBMET02858 0.46 0.009 DBMET02862 | DBMET02850 | |
| 0.597 | 0.002 | 0.792 | Glucocorticoid antagonist | 0.792 0.001 DB00860 0.644 0.002 DBMET02848 0.465 0.002 DBMET02849 0.465 0.002 DBMET02850 0.662 0.001 DBMET02851 0.662 0.001 DBMET02853 0.671 0.001 DB00635 0.365 0.002 DBMET02852 0.365 0.002 DBMET02854 0.672 0.001 DBMET02856 0.365 0.002 DBMET02857 0.514 0.002 DBMET02859 0.342 0.002 DBMET02860 0.342 0.002 DBMET02861 0.489 0.002 DBMET02863 0.489 0.002 DBMET02864 0.362 0.002 DBMET02855 0.362 0.002 DBMET02858 0.291 0.003 DBMET02862 | DB00860 | |
| 0.596 | 0.008 | 0.596 | DNA synthesis inhibitor | 0.584 0.008 DB00860 0.537 0.011 DBMET02848 0.507 0.013 DBMET02849 0.507 0.013 DBMET02850 0.542 0.011 DBMET02851 0.542 0.011 DBMET02853 0.48 0.015 DB00635 0.458 0.016 DBMET02852 0.458 0.016 DBMET02854 0.48 0.015 DBMET02856 0.458 0.016 DBMET02857 0.416 0.02 DBMET02859 0.394 0.022 DBMET02860 0.394 0.022 DBMET02861 0.478 0.015 DBMET02863 0.478 0.015 DBMET02864 0.383 0.024 DBMET02855 0.383 0.024 DBMET02858 0.278 0.052 DBMET02862 | ||
| 0.595 | 0.019 | 0.748 | Cholesterol antagonist | 0.575 0.022 DB00860 0.451 0.04 DBMET02848 0.599 0.019 DBMET02849 0.599 0.019 DBMET02850 0.466 0.038 DBMET02851 0.466 0.038 DBMET02853 0.654 0.012 DB00635 0.5 0.033 DBMET02852 0.5 0.033 DBMET02854 0.633 0.014 DBMET02856 0.5 0.033 DBMET02857 0.572 0.022 DBMET02859 0.679 0.01 DBMET02860 0.679 0.01 DBMET02861 0.634 0.014 DBMET02863 0.634 0.014 DBMET02864 0.65 0.012 DBMET02855 0.65 0.012 DBMET02858 0.748 0.005 DBMET02862 | DBMET02862 | |
| 0.577 | 0.005 | 0.632 | P-glycoprotein inhibitor | 0.602 0.005 DB00860 0.561 0.005 DBMET02848 0.35 0.021 DBMET02849 0.35 0.021 DBMET02850 0.632 0.004 DBMET02851 0.632 0.004 DBMET02853 0.552 0.005 DB00635 0.431 0.013 DBMET02852 0.431 0.013 DBMET02854 0.624 0.005 DBMET02856 0.431 0.013 DBMET02857 0.511 0.008 DBMET02859 0.279 0.033 DBMET02860 0.279 0.033 DBMET02861 0.607 0.005 DBMET02863 0.607 0.005 DBMET02864 0.401 0.016 DBMET02855 0.401 0.016 DBMET02858 0.27 0.036 DBMET02862 | DBMET02853 | |
| 0.571 | 0.005 | 0.684 | Anesthetic general | 0.5 0.008 DB00860 0.421 0.014 DBMET02848 0.381 0.019 DBMET02849 0.381 0.019 DBMET02850 0.403 0.016 DBMET02851 0.403 0.016 DBMET02853 0.655 0.004 DB00635 0.279 0.039 DBMET02852 0.279 0.039 DBMET02854 0.673 0.004 DBMET02856 0.279 0.039 DBMET02857 0.584 0.005 DBMET02859 0.552 0.005 DBMET02860 0.552 0.005 DBMET02861 0.615 0.004 DBMET02863 0.615 0.004 DBMET02864 0.564 0.005 DBMET02855 0.564 0.005 DBMET02858 0.684 0.004 DBMET02862 | DBMET02862 | |
| 0.547 | 0.003 | 0.676 | Interleukin 8 antagonist | 0.676 0.003 DB00860 0.32 0.004 DBMET02848 0.348 0.004 DBMET02849 0.348 0.004 DBMET02850 0.359 0.004 DBMET02851 0.359 0.004 DBMET02853 0.258 0.005 DB00635 0.203 0.012 DBMET02852 0.203 0.012 DBMET02854 0.253 0.005 DBMET02856 0.203 0.012 DBMET02857 0.146 0.037 DBMET02859 0.15 0.034 DBMET02860 0.15 0.034 DBMET02861 0.16 0.028 DBMET02863 0.16 0.028 DBMET02864 0.152 0.033 DBMET02855 0.152 0.033 DBMET02858 | DB00860 | |
| 0.532 | 0.014 | 0.736 | Nitric oxide antagonist | 0.566 0.012 DB00860 0.518 0.015 DBMET02848 0.517 0.015 DBMET02849 0.517 0.015 DBMET02850 0.616 0.009 DBMET02851 0.616 0.009 DBMET02853 0.693 0.006 DB00635 0.57 0.011 DBMET02852 0.57 0.011 DBMET02854 0.584 0.01 DBMET02856 0.57 0.011 DBMET02857 0.642 0.008 DBMET02859 0.638 0.008 DBMET02860 0.638 0.008 DBMET02861 0.736 0.005 DBMET02863 0.736 0.005 DBMET02864 0.535 0.013 DBMET02855 0.535 0.013 DBMET02858 0.615 0.009 DBMET02862 | DBMET02864 | |
| 0.5 | 0.005 | 0.5 | Alkylator | 0.432 0.006 DB00860 0.419 0.007 DBMET02848 0.261 0.015 DBMET02849 0.261 0.015 DBMET02850 0.422 0.007 DBMET02851 0.422 0.007 DBMET02853 0.235 0.018 DB00635 0.251 0.016 DBMET02852 0.251 0.016 DBMET02854 0.289 0.013 DBMET02856 0.251 0.016 DBMET02857 0.227 0.02 DBMET02859 0.145 0.049 DBMET02860 0.145 0.049 DBMET02861 0.265 0.015 DBMET02863 0.265 0.015 DBMET02864 0.169 0.037 DBMET02855 0.169 0.037 DBMET02858 0.102 0.086 DBMET02862 | ||
| 0.492 | 0.005 | 0.541 | Lipid peroxidase inhibitor | 0.486 0.005 DB00860 0.456 0.007 DBMET02848 0.541 0.005 DBMET02849 0.541 0.005 DBMET02850 0.422 0.009 DBMET02851 0.422 0.009 DBMET02853 0.442 0.008 DB00635 0.493 0.005 DBMET02852 0.493 0.005 DBMET02854 0.325 0.016 DBMET02856 0.493 0.005 DBMET02857 0.397 0.01 DBMET02859 0.506 0.005 DBMET02860 0.506 0.005 DBMET02861 0.349 0.013 DBMET02863 0.349 0.013 DBMET02864 0.414 0.009 DBMET02855 0.414 0.009 DBMET02858 0.367 0.011 DBMET02862 | DBMET02850 | |
| 0.485 | 0.008 | 0.489 | Monophenol monooxygenase inhibitor | 0.386 0.012 DB00860 0.253 0.024 DBMET02848 0.489 0.008 DBMET02849 0.489 0.008 DBMET02850 0.274 0.021 DBMET02851 0.274 0.021 DBMET02853 0.172 0.04 DB00635 0.342 0.014 DBMET02852 0.342 0.014 DBMET02854 0.2 0.033 DBMET02856 0.342 0.014 DBMET02857 0.105 0.072 DBMET02859 0.225 0.028 DBMET02860 0.225 0.028 DBMET02861 0.12 0.061 DBMET02863 0.12 0.061 DBMET02864 0.258 0.023 DBMET02855 0.258 0.023 DBMET02858 0.107 0.071 DBMET02862 | DBMET02850 | |
| 0.468 | 0.002 | 0.69 | Aldosterone antagonist | 0.69 0.001 DB00860 0.685 0.001 DBMET02848 0.507 0.002 DBMET02849 0.507 0.002 DBMET02850 0.497 0.002 DBMET02851 0.497 0.002 DBMET02853 0.449 0.002 DB00635 0.325 0.003 DBMET02852 0.325 0.003 DBMET02854 0.404 0.002 DBMET02856 0.325 0.003 DBMET02857 0.443 0.002 DBMET02859 0.273 0.003 DBMET02860 0.273 0.003 DBMET02861 0.265 0.003 DBMET02863 0.265 0.003 DBMET02864 0.22 0.004 DBMET02855 0.22 0.004 DBMET02858 0.088 0.009 DBMET02862 | DB00860 | |
| 0.467 | 0.005 | 0.507 | Sodium/bile acid cotransporter inhibitor | 0.482 0.005 DB00860 0.465 0.006 DBMET02848 0.482 0.005 DBMET02849 0.482 0.005 DBMET02850 0.494 0.004 DBMET02851 0.494 0.004 DBMET02853 0.439 0.009 DB00635 0.494 0.004 DBMET02852 0.494 0.004 DBMET02854 0.507 0.004 DBMET02856 0.494 0.004 DBMET02857 0.415 0.013 DBMET02859 0.441 0.009 DBMET02860 0.441 0.009 DBMET02861 0.459 0.006 DBMET02863 0.459 0.006 DBMET02864 0.507 0.004 DBMET02855 0.507 0.004 DBMET02858 0.488 0.004 DBMET02862 | DBMET02858 | |
| 0.44 | 0.001 | 0.552 | Anabolic | 0.431 0.001 DB00860 0.369 0.001 DBMET02848 0.552 0.001 DBMET02849 0.552 0.001 DBMET02850 0.317 0.001 DBMET02851 0.317 0.001 DBMET02853 0.334 0.001 DB00635 0.364 0.001 DBMET02852 0.364 0.001 DBMET02854 0.355 0.001 DBMET02856 0.364 0.001 DBMET02857 0.297 0.001 DBMET02859 0.417 0.001 DBMET02860 0.417 0.001 DBMET02861 0.313 0.001 DBMET02863 0.313 0.001 DBMET02864 0.416 0.001 DBMET02855 0.416 0.001 DBMET02858 0.388 0.001 DBMET02862 | DBMET02850 | |
| 0.442 | 0.005 | 0.536 | Interleukin 6 antagonist | 0.535 0.004 DB00860 0.493 0.005 DBMET02848 0.368 0.009 DBMET02849 0.368 0.009 DBMET02850 0.536 0.004 DBMET02851 0.536 0.004 DBMET02853 0.447 0.005 DB00635 0.375 0.009 DBMET02852 0.375 0.009 DBMET02854 0.499 0.005 DBMET02856 0.375 0.009 DBMET02857 0.411 0.007 DBMET02859 0.243 0.024 DBMET02860 0.243 0.024 DBMET02861 0.451 0.005 DBMET02863 0.451 0.005 DBMET02864 0.321 0.012 DBMET02855 0.321 0.012 DBMET02858 0.255 0.022 DBMET02862 | DBMET02853 | |
| 0.44 | 0.006 | 0.44 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.401 0.008 DB00860 0.331 0.016 DBMET02848 0.3 0.024 DBMET02849 0.3 0.024 DBMET02850 0.333 0.015 DBMET02851 0.333 0.015 DBMET02853 0.224 0.055 DB00635 0.222 0.056 DBMET02852 0.222 0.056 DBMET02854 0.37 0.01 DBMET02856 0.222 0.056 DBMET02857 0.161 0.124 DBMET02859 0.199 0.073 DBMET02863 0.199 0.073 DBMET02864 0.268 0.035 DBMET02855 0.268 0.035 DBMET02858 | ||
| 0.427 | 0 | 0.517 | Corticosteroid-like | 0.517 0 DB00860 0.436 0 DBMET02848 0.248 0.001 DBMET02849 0.248 0.001 DBMET02850 0.437 0 DBMET02851 0.437 0 DBMET02853 0.464 0 DB00635 0.189 0.001 DBMET02852 0.189 0.001 DBMET02854 0.415 0 DBMET02856 0.189 0.001 DBMET02857 0.369 0.001 DBMET02859 0.186 0.001 DBMET02860 0.186 0.001 DBMET02861 0.333 0.001 DBMET02863 0.333 0.001 DBMET02864 0.169 0.001 DBMET02855 0.169 0.001 DBMET02858 0.13 0.001 DBMET02862 | DB00860 | |
| 0.415 | 0.002 | 0.415 | 5-Alpha-reductase inhibitor | 0.398 0.002 DB00860 0.389 0.002 DBMET02848 0.392 0.002 DBMET02849 0.392 0.002 DBMET02850 0.322 0.003 DBMET02851 0.322 0.003 DBMET02853 0.403 0.002 DB00635 0.316 0.003 DBMET02852 0.316 0.003 DBMET02854 0.378 0.002 DBMET02856 0.316 0.003 DBMET02857 0.396 0.002 DBMET02859 0.396 0.002 DBMET02860 0.396 0.002 DBMET02861 0.326 0.003 DBMET02863 0.326 0.003 DBMET02864 0.37 0.002 DBMET02855 0.37 0.002 DBMET02858 0.399 0.002 DBMET02862 | ||
| 0.432 | 0.026 | 0.503 | Interleukin antagonist | 0.503 0.02 DB00860 0.443 0.025 DBMET02848 0.33 0.042 DBMET02849 0.33 0.042 DBMET02850 0.441 0.025 DBMET02851 0.441 0.025 DBMET02853 0.371 0.035 DB00635 0.258 0.059 DBMET02852 0.258 0.059 DBMET02854 0.399 0.031 DBMET02856 0.258 0.059 DBMET02857 0.296 0.049 DBMET02859 0.169 0.104 DBMET02860 0.169 0.104 DBMET02861 0.286 0.051 DBMET02863 0.286 0.051 DBMET02864 0.202 0.083 DBMET02855 0.202 0.083 DBMET02858 | DB00860 | |
| 0.466 | 0.075 | 0.661 | Caspase 9 stimulant | 0.478 0.069 DB00860 0.4 0.111 DBMET02848 0.465 0.075 DBMET02849 0.465 0.075 DBMET02850 0.474 0.071 DBMET02851 0.474 0.071 DBMET02853 0.355 0.141 DB00635 0.461 0.077 DBMET02852 0.461 0.077 DBMET02854 0.661 0.028 DBMET02856 0.461 0.077 DBMET02857 0.287 0.209 DBMET02859 0.351 0.145 DBMET02860 0.351 0.145 DBMET02861 0.398 0.112 DBMET02863 0.398 0.112 DBMET02864 0.636 0.031 DBMET02855 0.636 0.031 DBMET02858 0.514 0.054 DBMET02862 | DBMET02856 | |
| 0.4 | 0.035 | 0.512 | Antioxidant | 0.398 0.035 DB00860 0.349 0.047 DBMET02848 0.511 0.019 DBMET02849 0.511 0.019 DBMET02850 0.387 0.037 DBMET02851 0.387 0.037 DBMET02853 0.382 0.038 DB00635 0.5 0.02 DBMET02852 0.5 0.02 DBMET02854 0.396 0.036 DBMET02856 0.5 0.02 DBMET02857 0.332 0.051 DBMET02859 0.503 0.02 DBMET02860 0.503 0.02 DBMET02861 0.385 0.037 DBMET02863 0.385 0.037 DBMET02864 0.512 0.019 DBMET02855 0.512 0.019 DBMET02858 0.493 0.021 DBMET02862 | DBMET02858 | |
| 0.357 | 0 | 0.425 | Lipocortins synthesis agonist | 0.425 0 DB00860 0.364 0 DBMET02848 0.231 0.001 DBMET02849 0.231 0.001 DBMET02850 0.369 0 DBMET02851 0.369 0 DBMET02853 0.299 0.001 DB00635 0.21 0.001 DBMET02852 0.21 0.001 DBMET02854 0.295 0.001 DBMET02856 0.21 0.001 DBMET02857 0.245 0.001 DBMET02859 0.183 0.001 DBMET02860 0.183 0.001 DBMET02861 0.237 0.001 DBMET02863 0.237 0.001 DBMET02864 0.186 0.001 DBMET02855 0.186 0.001 DBMET02858 0.15 0.002 DBMET02862 | DB00860 | |
| 0.396 | 0.051 | 0.396 | Immunostimulant | 0.395 0.051 DB00860 0.36 0.062 DBMET02848 0.344 0.066 DBMET02849 0.344 0.066 DBMET02850 0.332 0.07 DBMET02851 0.332 0.07 DBMET02853 0.294 0.08 DB00635 0.26 0.092 DBMET02852 0.26 0.092 DBMET02854 0.365 0.06 DBMET02856 0.26 0.092 DBMET02857 0.243 0.099 DBMET02859 0.24 0.101 DBMET02860 0.24 0.101 DBMET02861 0.271 0.088 DBMET02863 0.271 0.088 DBMET02864 0.299 0.079 DBMET02855 0.299 0.079 DBMET02858 0.225 0.107 DBMET02862 | ||
| 0.35 | 0.012 | 0.509 | NOS3 expression enhancer | 0.509 0.005 DB00860 0.357 0.011 DBMET02848 0.335 0.013 DBMET02849 0.335 0.013 DBMET02850 0.404 0.008 DBMET02851 0.404 0.008 DBMET02853 0.468 0.005 DB00635 0.246 0.027 DBMET02852 0.246 0.027 DBMET02854 0.407 0.008 DBMET02856 0.246 0.027 DBMET02857 0.317 0.015 DBMET02859 0.289 0.019 DBMET02860 0.289 0.019 DBMET02861 0.37 0.01 DBMET02863 0.37 0.01 DBMET02864 0.24 0.029 DBMET02855 0.24 0.029 DBMET02858 0.173 0.054 DBMET02862 | DB00860 | |
| 0.378 | 0.045 | 0.479 | Apoptosis antagonist | 0.387 0.042 DB00860 0.349 0.056 DBMET02848 0.395 0.04 DBMET02849 0.395 0.04 DBMET02850 0.472 0.024 DBMET02851 0.472 0.024 DBMET02853 0.348 0.057 DB00635 0.479 0.023 DBMET02852 0.479 0.023 DBMET02854 0.391 0.041 DBMET02856 0.479 0.023 DBMET02857 0.313 0.077 DBMET02859 0.356 0.053 DBMET02860 0.356 0.053 DBMET02861 0.438 0.029 DBMET02863 0.438 0.029 DBMET02864 0.398 0.039 DBMET02855 0.398 0.039 DBMET02858 0.376 0.046 DBMET02862 | DBMET02857 | |
| 0.311 | 0.01 | 0.402 | Cholesterol synthesis inhibitor | 0.331 0.008 DB00860 0.228 0.021 DBMET02848 0.402 0.004 DBMET02849 0.402 0.004 DBMET02850 0.278 0.014 DBMET02851 0.278 0.014 DBMET02853 0.296 0.012 DB00635 0.358 0.006 DBMET02852 0.358 0.006 DBMET02854 0.315 0.01 DBMET02856 0.358 0.006 DBMET02857 0.187 0.03 DBMET02859 0.383 0.005 DBMET02860 0.383 0.005 DBMET02861 0.283 0.013 DBMET02863 0.283 0.013 DBMET02864 0.388 0.005 DBMET02855 0.388 0.005 DBMET02858 0.388 0.005 DBMET02862 | DBMET02850 | |
| 0.302 | 0.006 | 0.377 | Estrogen antagonist | 0.377 0.005 DB00860 0.32 0.005 DBMET02848 0.274 0.007 DBMET02849 0.274 0.007 DBMET02850 0.32 0.005 DBMET02851 0.32 0.005 DBMET02853 0.343 0.005 DB00635 0.229 0.01 DBMET02852 0.229 0.01 DBMET02854 0.31 0.006 DBMET02856 0.229 0.01 DBMET02857 0.286 0.007 DBMET02859 0.237 0.009 DBMET02860 0.237 0.009 DBMET02861 0.274 0.007 DBMET02863 0.274 0.007 DBMET02864 0.218 0.011 DBMET02855 0.218 0.011 DBMET02858 0.205 0.012 DBMET02862 | DB00860 | |
| 0.335 | 0.045 | 0.342 | DNA damaging | 0.342 0.043 DB00860 0.319 0.05 DBMET02848 0.247 0.082 DBMET02851 0.247 0.082 DBMET02853 0.242 0.085 DB00635 0.188 0.126 DBMET02856 0.224 0.097 DBMET02859 0.184 0.13 DBMET02863 0.184 0.13 DBMET02864 | DB00860 | |
| 0.292 | 0.006 | 0.36 | Farnesoid X receptor antagonist | 0.29 0.007 DB00860 0.221 0.016 DBMET02848 0.28 0.008 DBMET02849 0.28 0.008 DBMET02850 0.277 0.008 DBMET02851 0.277 0.008 DBMET02853 0.26 0.01 DB00635 0.267 0.009 DBMET02852 0.267 0.009 DBMET02854 0.36 0.004 DBMET02856 0.267 0.009 DBMET02857 0.181 0.029 DBMET02859 0.246 0.012 DBMET02860 0.246 0.012 DBMET02861 0.244 0.012 DBMET02863 0.244 0.012 DBMET02864 0.351 0.004 DBMET02855 0.351 0.004 DBMET02858 0.296 0.006 DBMET02862 | DBMET02856 | |
| 0.309 | 0.027 | 0.379 | Hepatoprotectant | 0.299 0.03 DB00860 0.288 0.033 DBMET02848 0.297 0.03 DBMET02849 0.297 0.03 DBMET02850 0.316 0.025 DBMET02851 0.316 0.025 DBMET02853 0.304 0.029 DB00635 0.314 0.026 DBMET02852 0.314 0.026 DBMET02854 0.379 0.015 DBMET02856 0.314 0.026 DBMET02857 0.293 0.032 DBMET02859 0.304 0.028 DBMET02860 0.304 0.028 DBMET02861 0.337 0.021 DBMET02863 0.337 0.021 DBMET02864 0.375 0.016 DBMET02855 0.375 0.016 DBMET02858 0.37 0.016 DBMET02862 | DBMET02856 | |
| 0.329 | 0.072 | 0.34 | Antithrombotic | 0.252 0.124 DB00860 0.34 0.068 DBMET02849 0.34 0.068 DBMET02850 0.219 0.155 DBMET02851 0.219 0.155 DBMET02853 0.301 0.087 DBMET02852 0.301 0.087 DBMET02854 0.301 0.087 DBMET02857 0.25 0.126 DBMET02855 0.25 0.126 DBMET02858 | DBMET02850 | |
| 0.273 | 0.027 | 0.28 | Neurotrophic factor enhancer | 0.28 0.024 DB00860 0.238 0.046 DBMET02848 0.263 0.032 DBMET02849 0.263 0.032 DBMET02850 0.273 0.027 DBMET02851 0.273 0.027 DBMET02853 0.268 0.029 DB00635 0.256 0.035 DBMET02852 0.256 0.035 DBMET02854 0.262 0.032 DBMET02856 0.256 0.035 DBMET02857 0.227 0.054 DBMET02859 0.254 0.036 DBMET02860 0.254 0.036 DBMET02861 0.273 0.027 DBMET02863 0.273 0.027 DBMET02864 0.246 0.041 DBMET02855 0.246 0.041 DBMET02858 0.259 0.034 DBMET02862 | DB00860 | |
| 0.249 | 0.004 | 0.378 | Mineralocorticoid receptor antagonist | 0.378 0.003 DB00860 0.344 0.004 DBMET02848 0.242 0.004 DBMET02849 0.242 0.004 DBMET02850 0.289 0.004 DBMET02851 0.289 0.004 DBMET02853 0.29 0.004 DB00635 0.17 0.005 DBMET02852 0.17 0.005 DBMET02854 0.312 0.004 DBMET02856 0.17 0.005 DBMET02857 0.26 0.004 DBMET02859 0.152 0.005 DBMET02860 0.152 0.005 DBMET02861 0.177 0.004 DBMET02863 0.177 0.004 DBMET02864 0.181 0.004 DBMET02855 0.181 0.004 DBMET02858 0.133 0.005 DBMET02862 | DB00860 | |
| 0.249 | 0.006 | 0.296 | Estrogen agonist | 0.273 0.005 DB00860 0.155 0.011 DBMET02848 0.264 0.006 DBMET02849 0.264 0.006 DBMET02850 0.224 0.007 DBMET02851 0.224 0.007 DBMET02853 0.296 0.005 DB00635 0.215 0.007 DBMET02852 0.215 0.007 DBMET02854 0.259 0.006 DBMET02856 0.215 0.007 DBMET02857 0.166 0.01 DBMET02859 0.281 0.005 DBMET02860 0.281 0.005 DBMET02861 0.24 0.007 DBMET02863 0.24 0.007 DBMET02864 0.249 0.006 DBMET02855 0.249 0.006 DBMET02858 0.284 0.005 DBMET02862 | DB00635 | |
| 0.254 | 0.013 | 0.287 | Interleukin 4 antagonist | 0.287 0.009 DB00860 0.276 0.01 DBMET02848 0.18 0.03 DBMET02849 0.18 0.03 DBMET02850 0.215 0.019 DBMET02851 0.215 0.019 DBMET02853 0.229 0.016 DB00635 0.137 0.064 DBMET02852 0.137 0.064 DBMET02854 0.179 0.03 DBMET02856 0.137 0.064 DBMET02857 0.219 0.018 DBMET02859 0.141 0.058 DBMET02860 0.141 0.058 DBMET02861 0.182 0.029 DBMET02863 0.182 0.029 DBMET02864 | DB00860 | |
| 0.234 | 0.006 | 0.234 | Antineoplastic alkaloid | 0.223 0.008 DB00860 0.21 0.011 DBMET02848 0.217 0.009 DBMET02849 0.217 0.009 DBMET02850 0.221 0.009 DBMET02851 0.221 0.009 DBMET02853 0.201 0.013 DB00635 0.216 0.01 DBMET02852 0.216 0.01 DBMET02854 0.207 0.012 DBMET02856 0.216 0.01 DBMET02857 0.18 0.019 DBMET02859 0.194 0.015 DBMET02860 0.194 0.015 DBMET02861 0.204 0.013 DBMET02863 0.204 0.013 DBMET02864 0.201 0.014 DBMET02855 0.201 0.014 DBMET02858 0.178 0.02 DBMET02862 | ||
| 0.301 | 0.073 | 0.368 | Interleukin 2 agonist | 0.333 0.054 DB00860 0.23 0.143 DBMET02848 0.368 0.038 DBMET02849 0.368 0.038 DBMET02850 0.264 0.104 DBMET02851 0.264 0.104 DBMET02853 0.307 0.069 DB00635 0.307 0.069 DBMET02852 0.307 0.069 DBMET02854 0.267 0.1 DBMET02856 0.307 0.069 DBMET02857 0.351 0.045 DBMET02860 0.351 0.045 DBMET02861 0.264 0.104 DBMET02863 0.264 0.104 DBMET02864 0.311 0.066 DBMET02855 0.311 0.066 DBMET02858 0.298 0.075 DBMET02862 | DBMET02850 | |
| 0.264 | 0.038 | 0.264 | Non-steroidal antiinflammatory agent | 0.149 0.116 DB00860 0.2 0.071 DBMET02848 | ||
| 0.223 | 0.005 | 0.329 | Interleukin 5 antagonist | 0.329 0.004 DB00860 0.239 0.005 DBMET02848 0.215 0.005 DBMET02849 0.215 0.005 DBMET02850 0.239 0.005 DBMET02851 0.239 0.005 DBMET02853 0.219 0.005 DB00635 0.169 0.008 DBMET02852 0.169 0.008 DBMET02854 0.182 0.007 DBMET02856 0.169 0.008 DBMET02857 0.169 0.008 DBMET02859 0.153 0.01 DBMET02860 0.153 0.01 DBMET02861 0.163 0.009 DBMET02863 0.163 0.009 DBMET02864 0.132 0.017 DBMET02855 0.132 0.017 DBMET02858 0.083 0.066 DBMET02862 | DB00860 | |
| 0.342 | 0.128 | 0.382 | Cyclophilin D inhibitor | 0.382 0.101 DB00860 0.309 0.154 DBMET02848 0.358 0.117 DBMET02849 0.358 0.117 DBMET02850 0.321 0.145 DBMET02851 0.321 0.145 DBMET02853 0.348 0.124 DB00635 0.297 0.165 DBMET02852 0.297 0.165 DBMET02854 0.365 0.112 DBMET02856 0.297 0.165 DBMET02857 0.268 0.193 DBMET02859 0.338 0.131 DBMET02860 0.338 0.131 DBMET02861 0.342 0.128 DBMET02863 0.342 0.128 DBMET02864 0.34 0.13 DBMET02855 0.34 0.13 DBMET02858 0.339 0.131 DBMET02862 | DB00860 | |
| 0.224 | 0.015 | 0.246 | Microtubule formation inhibitor | 0.182 0.024 DB00860 0.146 0.04 DBMET02848 0.224 0.015 DBMET02849 0.224 0.015 DBMET02850 0.173 0.028 DBMET02851 0.173 0.028 DBMET02853 0.103 0.085 DB00635 0.214 0.017 DBMET02852 0.214 0.017 DBMET02854 0.218 0.016 DBMET02856 0.214 0.017 DBMET02857 0.135 0.047 DBMET02860 0.135 0.047 DBMET02861 0.12 0.06 DBMET02863 0.12 0.06 DBMET02864 0.246 0.01 DBMET02855 0.246 0.01 DBMET02858 0.175 0.027 DBMET02862 | DBMET02858 | |
| 0.232 | 0.032 | 0.247 | Melanin inhibitor | 0.227 0.033 DB00860 0.168 0.061 DBMET02848 0.247 0.029 DBMET02849 0.247 0.029 DBMET02850 0.158 0.072 DBMET02851 0.158 0.072 DBMET02853 0.196 0.042 DB00635 0.165 0.064 DBMET02852 0.165 0.064 DBMET02854 0.173 0.057 DBMET02856 0.165 0.064 DBMET02857 0.153 0.078 DBMET02859 0.217 0.035 DBMET02860 0.217 0.035 DBMET02861 0.161 0.068 DBMET02863 0.161 0.068 DBMET02864 0.181 0.051 DBMET02855 0.181 0.051 DBMET02858 0.181 0.051 DBMET02862 | DBMET02850 | |
| 0.187 | 0.002 | 0.288 | Progesterone agonist | 0.22 0.002 DB00860 0.263 0.002 DBMET02848 0.162 0.003 DBMET02849 0.162 0.003 DBMET02850 0.197 0.002 DBMET02851 0.197 0.002 DBMET02853 0.246 0.002 DB00635 0.145 0.003 DBMET02852 0.145 0.003 DBMET02854 0.22 0.002 DBMET02856 0.145 0.003 DBMET02857 0.288 0.002 DBMET02859 0.166 0.003 DBMET02860 0.166 0.003 DBMET02861 0.192 0.002 DBMET02863 0.192 0.002 DBMET02864 0.161 0.003 DBMET02855 0.161 0.003 DBMET02858 0.178 0.002 DBMET02862 | DBMET02859 | |
| 0.183 | 0.003 | 0.229 | 5-Alpha-reductase 1 inhibitor | 0.193 0.003 DB00860 0.166 0.003 DBMET02848 0.195 0.003 DBMET02849 0.195 0.003 DBMET02850 0.085 0.005 DBMET02851 0.085 0.005 DBMET02853 0.229 0.003 DB00635 0.087 0.005 DBMET02852 0.087 0.005 DBMET02854 0.139 0.004 DBMET02856 0.087 0.005 DBMET02857 0.197 0.003 DBMET02859 0.222 0.003 DBMET02860 0.222 0.003 DBMET02861 0.091 0.005 DBMET02863 0.091 0.005 DBMET02864 0.142 0.004 DBMET02855 0.142 0.004 DBMET02858 0.219 0.003 DBMET02862 | DB00635 | |
| 0.192 | 0.022 | 0.293 | Antineoplastic antibiotic | 0.241 0.015 DB00860 0.25 0.014 DBMET02848 0.225 0.017 DBMET02849 0.225 0.017 DBMET02850 0.269 0.012 DBMET02851 0.269 0.012 DBMET02853 0.249 0.014 DB00635 0.254 0.014 DBMET02852 0.254 0.014 DBMET02854 0.278 0.011 DBMET02856 0.254 0.014 DBMET02857 0.258 0.013 DBMET02859 0.234 0.016 DBMET02860 0.234 0.016 DBMET02861 0.293 0.01 DBMET02863 0.293 0.01 DBMET02864 0.262 0.013 DBMET02855 0.262 0.013 DBMET02858 0.261 0.013 DBMET02862 | DBMET02864 | |
| 0.196 | 0.026 | 0.196 | Adenylate cyclase inhibitor | 0.169 0.034 DB00860 0.112 0.074 DBMET02848 0.185 0.029 DBMET02849 0.185 0.029 DBMET02850 0.105 0.08 DBMET02852 0.105 0.08 DBMET02854 0.15 0.045 DBMET02856 0.105 0.08 DBMET02857 0.164 0.037 DBMET02855 0.164 0.037 DBMET02858 | ||
| 0.171 | 0.004 | 0.273 | RNA-directed RNA polymerase stimulant | 0.203 0.003 DB00860 0.106 0.006 DBMET02848 0.194 0.003 DBMET02849 0.194 0.003 DBMET02850 0.142 0.004 DBMET02851 0.142 0.004 DBMET02853 0.194 0.003 DB00635 0.136 0.004 DBMET02852 0.136 0.004 DBMET02854 0.222 0.003 DBMET02856 0.136 0.004 DBMET02857 0.094 0.007 DBMET02859 0.185 0.003 DBMET02860 0.185 0.003 DBMET02861 0.142 0.004 DBMET02863 0.142 0.004 DBMET02864 0.213 0.003 DBMET02855 0.213 0.003 DBMET02858 0.273 0.002 DBMET02862 | DBMET02862 | |
| 0.169 | 0.013 | 0.213 | Toll-Like receptor 4 antagonist | 0.169 0.013 DB00860 0.158 0.017 DBMET02848 0.213 0.005 DBMET02849 0.213 0.005 DBMET02850 0.162 0.015 DBMET02851 0.162 0.015 DBMET02853 0.165 0.014 DB00635 0.206 0.005 DBMET02852 0.206 0.005 DBMET02854 0.138 0.028 DBMET02856 0.206 0.005 DBMET02857 0.153 0.019 DBMET02859 0.213 0.005 DBMET02860 0.213 0.005 DBMET02861 0.162 0.015 DBMET02863 0.162 0.015 DBMET02864 0.192 0.007 DBMET02855 0.192 0.007 DBMET02858 0.186 0.008 DBMET02862 | DBMET02861 | |
| 0.233 | 0.078 | 0.339 | Angiogenesis stimulant | 0.264 0.064 DB00860 0.202 0.093 DBMET02848 0.247 0.071 DBMET02849 0.247 0.071 DBMET02850 0.233 0.078 DBMET02851 0.233 0.078 DBMET02853 0.215 0.087 DBMET02852 0.215 0.087 DBMET02854 0.339 0.036 DBMET02856 0.215 0.087 DBMET02857 0.136 0.131 DBMET02863 0.136 0.131 DBMET02864 0.326 0.04 DBMET02855 0.326 0.04 DBMET02858 0.136 0.132 DBMET02862 | DBMET02856 | |
| 0.157 | 0.004 | 0.241 | 5-Alpha-reductase 2 inhibitor | 0.167 0.004 DB00860 0.133 0.004 DBMET02848 0.213 0.003 DBMET02849 0.213 0.003 DBMET02850 0.058 0.007 DBMET02851 0.058 0.007 DBMET02853 0.193 0.003 DB00635 0.112 0.005 DBMET02852 0.112 0.005 DBMET02854 0.128 0.004 DBMET02856 0.112 0.005 DBMET02857 0.155 0.004 DBMET02859 0.23 0.003 DBMET02860 0.23 0.003 DBMET02861 0.078 0.006 DBMET02863 0.078 0.006 DBMET02864 0.173 0.003 DBMET02855 0.173 0.003 DBMET02858 0.241 0.002 DBMET02862 | DBMET02862 | |
| 0.195 | 0.043 | 0.214 | Protein kinase stimulant | 0.118 0.095 DB00860 0.203 0.04 DBMET02848 0.124 0.088 DB00635 0.132 0.081 DBMET02856 0.214 0.037 DBMET02859 0.116 0.096 DBMET02860 0.116 0.096 DBMET02861 0.147 0.07 DBMET02863 0.147 0.07 DBMET02864 0.116 0.097 DBMET02855 0.116 0.097 DBMET02858 0.134 0.08 DBMET02862 | DBMET02859 | |
| 0.256 | 0.107 | 0.469 | Caspase 3 stimulant | 0.292 0.083 DB00860 0.285 0.087 DBMET02848 0.384 0.049 DBMET02851 0.384 0.049 DBMET02853 0.243 0.118 DB00635 0.232 0.129 DBMET02852 0.232 0.129 DBMET02854 0.469 0.025 DBMET02856 0.232 0.129 DBMET02857 0.239 0.123 DBMET02859 0.349 0.059 DBMET02863 0.349 0.059 DBMET02864 0.33 0.066 DBMET02855 0.33 0.066 DBMET02858 0.285 0.087 DBMET02862 | DBMET02856 | |
| 0.229 | 0.086 | 0.387 | Tumour necrosis factor alpha release inhibitor | 0.291 0.057 DB00860 0.315 0.048 DBMET02848 0.345 0.039 DBMET02849 0.345 0.039 DBMET02850 0.251 0.075 DBMET02851 0.251 0.075 DBMET02853 0.307 0.05 DBMET02852 0.307 0.05 DBMET02854 0.337 0.041 DBMET02856 0.307 0.05 DBMET02857 0.173 0.132 DBMET02860 0.173 0.132 DBMET02861 0.387 0.029 DBMET02855 0.387 0.029 DBMET02858 0.161 0.143 DBMET02862 | DBMET02858 | |
| 0.145 | 0.005 | 0.179 | Estrogen receptor alpha agonist | 0.179 0.005 DB00860 0.096 0.009 DBMET02848 0.175 0.005 DBMET02849 0.175 0.005 DBMET02850 0.112 0.007 DBMET02851 0.112 0.007 DBMET02853 0.154 0.005 DB00635 0.111 0.007 DBMET02852 0.111 0.007 DBMET02854 0.136 0.005 DBMET02856 0.111 0.007 DBMET02857 0.084 0.011 DBMET02859 0.149 0.005 DBMET02860 0.149 0.005 DBMET02861 0.1 0.009 DBMET02863 0.1 0.009 DBMET02864 0.133 0.006 DBMET02855 0.133 0.006 DBMET02858 0.137 0.005 DBMET02862 | DB00860 | |
| 0.149 | 0.012 | 0.237 | Estrogen receptor alpha antagonist | 0.237 0.006 DB00860 0.122 0.018 DBMET02848 0.213 0.008 DBMET02849 0.213 0.008 DBMET02850 0.166 0.01 DBMET02851 0.166 0.01 DBMET02853 0.108 0.023 DB00635 0.149 0.012 DBMET02852 0.149 0.012 DBMET02854 0.195 0.008 DBMET02856 0.149 0.012 DBMET02857 0.074 0.058 DBMET02859 0.103 0.025 DBMET02860 0.103 0.025 DBMET02861 0.094 0.031 DBMET02863 0.094 0.031 DBMET02864 0.171 0.01 DBMET02855 0.171 0.01 DBMET02858 0.107 0.023 DBMET02862 | DB00860 | |
| 0.174 | 0.04 | 0.357 | Topoisomerase II inhibitor | 0.337 0.014 DB00860 0.315 0.016 DBMET02848 0.301 0.018 DBMET02851 0.301 0.018 DBMET02853 0.357 0.013 DB00635 0.26 0.023 DBMET02856 0.334 0.014 DBMET02859 0.312 0.016 DBMET02863 0.312 0.016 DBMET02864 | DB00635 | |
| 0.14 | 0.008 | 0.172 | Na+ K+ transporting ATPase inhibitor | 0.147 0.006 DB00860 0.126 0.013 DBMET02848 0.152 0.005 DBMET02849 0.152 0.005 DBMET02850 0.139 0.008 DBMET02851 0.139 0.008 DBMET02853 0.138 0.009 DB00635 0.143 0.007 DBMET02852 0.143 0.007 DBMET02854 0.166 0.004 DBMET02856 0.143 0.007 DBMET02857 0.118 0.017 DBMET02859 0.145 0.007 DBMET02860 0.145 0.007 DBMET02861 0.139 0.008 DBMET02863 0.139 0.008 DBMET02864 0.172 0.003 DBMET02855 0.172 0.003 DBMET02858 0.158 0.005 DBMET02862 | DBMET02858 | |
| 0.143 | 0.017 | 0.222 | Transcription factor NF kappa B stimulant | 0.144 0.017 DB00860 0.141 0.018 DBMET02848 0.174 0.012 DBMET02849 0.174 0.012 DBMET02850 0.146 0.017 DBMET02851 0.146 0.017 DBMET02853 0.188 0.01 DB00635 0.176 0.012 DBMET02852 0.176 0.012 DBMET02854 0.104 0.035 DBMET02856 0.176 0.012 DBMET02857 0.183 0.011 DBMET02859 0.222 0.007 DBMET02860 0.222 0.007 DBMET02861 0.192 0.01 DBMET02863 0.192 0.01 DBMET02864 0.129 0.021 DBMET02855 0.129 0.021 DBMET02858 0.166 0.013 DBMET02862 | DBMET02861 | |
| 0.128 | 0.003 | 0.128 | Nitric oxide donor | 0.125 0.004 DB00860 0.12 0.004 DBMET02848 0.107 0.006 DBMET02849 0.107 0.006 DBMET02850 0.121 0.004 DBMET02851 0.121 0.004 DBMET02853 0.119 0.004 DB00635 0.101 0.008 DBMET02852 0.101 0.008 DBMET02854 0.115 0.004 DBMET02856 0.101 0.008 DBMET02857 0.114 0.004 DBMET02859 0.097 0.01 DBMET02860 0.097 0.01 DBMET02861 0.114 0.004 DBMET02863 0.114 0.004 DBMET02864 0.088 0.015 DBMET02855 0.088 0.015 DBMET02858 0.066 0.039 DBMET02862 | ||
| 0.165 | 0.041 | 0.181 | Adenylate cyclase stimulant | 0.161 0.046 DB00860 0.148 0.066 DBMET02848 0.181 0.025 DBMET02849 0.181 0.025 DBMET02850 0.157 0.052 DBMET02851 0.157 0.052 DBMET02853 0.124 0.114 DB00635 0.176 0.029 DBMET02852 0.176 0.029 DBMET02854 0.157 0.052 DBMET02856 0.176 0.029 DBMET02857 0.15 0.062 DBMET02860 0.15 0.062 DBMET02861 0.14 0.08 DBMET02863 0.14 0.08 DBMET02864 0.177 0.029 DBMET02855 0.177 0.029 DBMET02858 0.141 0.078 DBMET02862 | DBMET02850 | |
| 0.164 | 0.042 | 0.181 | DNA polymerase I inhibitor | 0.181 0.035 DB00860 0.144 0.052 DBMET02848 0.179 0.035 DBMET02849 0.179 0.035 DBMET02850 0.16 0.044 DBMET02851 0.16 0.044 DBMET02853 0.158 0.045 DB00635 0.159 0.044 DBMET02852 0.159 0.044 DBMET02854 0.159 0.044 DBMET02856 0.159 0.044 DBMET02857 0.117 0.07 DBMET02859 0.163 0.043 DBMET02860 0.163 0.043 DBMET02861 0.16 0.044 DBMET02863 0.16 0.044 DBMET02864 0.158 0.045 DBMET02855 0.158 0.045 DBMET02858 0.153 0.048 DBMET02862 | DB00860 | |
| 0.14 | 0.018 | 0.164 | Estrogen receptor beta antagonist | 0.164 0.013 DB00860 0.132 0.022 DBMET02848 0.139 0.019 DBMET02849 0.139 0.019 DBMET02850 0.141 0.018 DBMET02851 0.141 0.018 DBMET02853 0.155 0.014 DB00635 0.126 0.026 DBMET02852 0.126 0.026 DBMET02854 0.146 0.016 DBMET02856 0.126 0.026 DBMET02857 0.127 0.025 DBMET02859 0.133 0.021 DBMET02860 0.133 0.021 DBMET02861 0.132 0.022 DBMET02863 0.132 0.022 DBMET02864 0.129 0.024 DBMET02855 0.129 0.024 DBMET02858 0.132 0.022 DBMET02862 | DB00860 | |
| 0.153 | 0.035 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.163 0.02 DB00860 0.16 0.023 DBMET02848 0.141 0.069 DBMET02849 0.141 0.069 DBMET02850 0.158 0.026 DBMET02851 0.158 0.026 DBMET02853 0.155 0.031 DB00635 0.137 0.085 DBMET02852 0.137 0.085 DBMET02854 0.163 0.02 DBMET02856 0.137 0.085 DBMET02857 0.153 0.036 DBMET02859 0.137 0.085 DBMET02860 0.137 0.085 DBMET02861 0.158 0.026 DBMET02863 0.158 0.026 DBMET02864 0.141 0.069 DBMET02855 0.141 0.069 DBMET02858 0.141 0.069 DBMET02862 | DBMET02856 | |
| 0.108 | 0.006 | 0.191 | Heme oxygenase stimulant | 0.116 0.005 DB00860 0.112 0.005 DBMET02848 0.111 0.005 DBMET02849 0.111 0.005 DBMET02850 0.111 0.005 DBMET02851 0.111 0.005 DBMET02853 0.191 0.002 DB00635 0.106 0.006 DBMET02852 0.106 0.006 DBMET02854 0.066 0.032 DBMET02856 0.106 0.006 DBMET02857 0.185 0.002 DBMET02859 0.18 0.002 DBMET02860 0.18 0.002 DBMET02861 0.173 0.002 DBMET02863 0.173 0.002 DBMET02864 0.061 0.042 DBMET02855 0.061 0.042 DBMET02858 0.135 0.003 DBMET02862 | DB00635 | |
| 0.129 | 0.027 | 0.306 | Topoisomerase II alpha inhibitor | 0.301 0.007 DB00860 0.284 0.008 DBMET02848 0.264 0.009 DBMET02851 0.264 0.009 DBMET02853 0.306 0.007 DB00635 0.281 0.008 DBMET02856 0.289 0.008 DBMET02859 0.264 0.009 DBMET02863 0.264 0.009 DBMET02864 | DB00635 | |
| 0.134 | 0.034 | 0.18 | Beta glucuronidase inhibitor | 0.168 0.018 DB00860 0.144 0.028 DBMET02848 0.18 0.016 DBMET02849 0.18 0.016 DBMET02850 0.124 0.042 DBMET02851 0.124 0.042 DBMET02853 0.11 0.057 DB00635 0.131 0.037 DBMET02852 0.131 0.037 DBMET02854 0.096 0.076 DBMET02856 0.131 0.037 DBMET02857 0.093 0.082 DBMET02859 0.116 0.049 DBMET02860 0.116 0.049 DBMET02861 0.102 0.067 DBMET02855 0.102 0.067 DBMET02858 | DBMET02850 | |
| 0.108 | 0.01 | 0.133 | Estrogen receptor beta agonist | 0.133 0.008 DB00860 0.075 0.015 DBMET02848 0.13 0.009 DBMET02849 0.13 0.009 DBMET02850 0.088 0.013 DBMET02851 0.088 0.013 DBMET02853 0.115 0.01 DB00635 0.086 0.013 DBMET02852 0.086 0.013 DBMET02854 0.115 0.01 DBMET02856 0.086 0.013 DBMET02857 0.05 0.019 DBMET02859 0.114 0.01 DBMET02860 0.114 0.01 DBMET02861 0.07 0.016 DBMET02863 0.07 0.016 DBMET02864 0.113 0.01 DBMET02855 0.113 0.01 DBMET02858 0.113 0.01 DBMET02862 | DB00860 | |
| 0.169 | 0.074 | 0.169 | Growth hormone agonist | 0.153 0.085 DB00860 0.137 0.099 DBMET02848 0.143 0.093 DBMET02849 0.143 0.093 DBMET02850 0.129 0.109 DBMET02851 0.129 0.109 DBMET02853 0.121 0.12 DBMET02852 0.121 0.12 DBMET02854 0.138 0.098 DBMET02856 0.121 0.12 DBMET02857 0.13 0.107 DBMET02855 0.13 0.107 DBMET02858 | ||
| 0.196 | 0.101 | 0.196 | Free radical scavenger | 0.156 0.138 DB00860 0.186 0.11 DBMET02849 0.186 0.11 DBMET02850 0.16 0.134 DBMET02855 0.16 0.134 DBMET02858 | ||
| 0.26 | 0.168 | 0.425 | Antibacterial | 0.28 0.151 DB00860 0.268 0.16 DBMET02848 0.325 0.117 DBMET02849 0.325 0.117 DBMET02850 0.322 0.119 DBMET02851 0.322 0.119 DBMET02853 0.23 0.196 DB00635 0.368 0.092 DBMET02852 0.368 0.092 DBMET02854 0.383 0.085 DBMET02856 0.368 0.092 DBMET02857 0.22 0.207 DBMET02859 0.296 0.138 DBMET02860 0.296 0.138 DBMET02861 0.345 0.105 DBMET02863 0.345 0.105 DBMET02864 0.425 0.066 DBMET02855 0.425 0.066 DBMET02858 0.395 0.079 DBMET02862 | DBMET02858 | |
| 0.116 | 0.026 | 0.265 | Inducible nitric-oxide synthase inhibitor | 0.188 0.01 DB00860 0.112 0.028 DBMET02848 0.159 0.014 DBMET02851 0.159 0.014 DBMET02853 0.265 0.005 DB00635 0.171 0.012 DBMET02856 0.172 0.012 DBMET02859 0.091 0.046 DBMET02860 0.091 0.046 DBMET02861 0.203 0.008 DBMET02863 0.203 0.008 DBMET02864 0.089 0.048 DBMET02862 | DB00635 | |
| 0.145 | 0.063 | 0.145 | Bone formation stimulant | 0.141 0.066 DB00860 0.135 0.072 DBMET02849 0.135 0.072 DBMET02850 0.11 0.095 DB00635 0.121 0.084 DBMET02856 0.113 0.092 DBMET02855 0.113 0.092 DBMET02858 | ||
| 0.186 | 0.105 | 0.215 | Hypolipemic | 0.175 0.114 DBMET02849 0.175 0.114 DBMET02850 0.148 0.139 DBMET02851 0.148 0.139 DBMET02853 0.215 0.085 DBMET02852 0.215 0.085 DBMET02854 0.215 0.085 DBMET02857 0.187 0.104 DBMET02860 0.187 0.104 DBMET02861 0.179 0.11 DBMET02863 0.179 0.11 DBMET02864 0.198 0.095 DBMET02855 0.198 0.095 DBMET02858 0.2 0.094 DBMET02862 | DBMET02857 | |
| 0.086 | 0.005 | 0.25 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.131 0.004 DB00860 0.092 0.005 DBMET02848 0.132 0.004 DBMET02849 0.132 0.004 DBMET02850 0.037 0.008 DBMET02851 0.037 0.008 DBMET02853 0.225 0.003 DB00635 0.037 0.008 DBMET02852 0.037 0.008 DBMET02854 0.066 0.005 DBMET02856 0.037 0.008 DBMET02857 0.17 0.004 DBMET02859 0.25 0.003 DBMET02860 0.25 0.003 DBMET02861 0.134 0.004 DBMET02863 0.134 0.004 DBMET02864 0.067 0.005 DBMET02855 0.067 0.005 DBMET02858 0.109 0.004 DBMET02862 | DBMET02861 | |
| 0.206 | 0.126 | 0.206 | Transcription factor STAT3 inhibitor | 0.186 0.155 DBMET02851 0.186 0.155 DBMET02853 | ||
| 0.091 | 0.012 | 0.14 | Estradiol 17 beta-dehydrogenase inhibitor | 0.139 0.007 DB00860 0.06 0.019 DBMET02848 0.14 0.007 DBMET02849 0.14 0.007 DBMET02850 0.076 0.014 DBMET02851 0.076 0.014 DBMET02853 0.088 0.012 DB00635 0.077 0.014 DBMET02852 0.077 0.014 DBMET02854 0.097 0.011 DBMET02856 0.077 0.014 DBMET02857 0.038 0.033 DBMET02859 0.089 0.012 DBMET02860 0.089 0.012 DBMET02861 0.053 0.023 DBMET02863 0.053 0.023 DBMET02864 0.097 0.011 DBMET02855 0.097 0.011 DBMET02858 0.087 0.012 DBMET02862 | DBMET02850 | |
| 0.118 | 0.041 | 0.118 | Breast cancer-resistant protein inhibitor | 0.116 0.042 DB00860 0.089 0.067 DBMET02848 0.086 0.071 DBMET02849 0.086 0.071 DBMET02850 0.094 0.061 DBMET02851 0.094 0.061 DBMET02853 | ||
| 0.081 | 0.004 | 0.265 | Glucose-6-phosphate dehydrogenase inhibitor | 0.132 0.002 DB00860 0.103 0.003 DBMET02848 0.065 0.006 DBMET02849 0.065 0.006 DBMET02850 0.132 0.002 DBMET02851 0.132 0.002 DBMET02853 0.265 0.001 DB00635 0.066 0.005 DBMET02852 0.066 0.005 DBMET02854 0.14 0.002 DBMET02856 0.066 0.005 DBMET02857 0.157 0.002 DBMET02859 0.094 0.003 DBMET02860 0.094 0.003 DBMET02861 0.224 0.002 DBMET02863 0.224 0.002 DBMET02864 0.068 0.005 DBMET02855 0.068 0.005 DBMET02858 0.114 0.003 DBMET02862 | DB00635 | |
| 0.213 | 0.148 | 0.259 | Immunomodulator | 0.244 0.12 DB00860 0.203 0.16 DBMET02848 0.184 0.183 DBMET02849 0.184 0.183 DBMET02850 0.253 0.112 DBMET02851 0.253 0.112 DBMET02853 0.195 0.17 DBMET02852 0.195 0.17 DBMET02854 0.259 0.108 DBMET02856 0.195 0.17 DBMET02857 0.205 0.158 DBMET02863 0.205 0.158 DBMET02864 0.198 0.167 DBMET02855 0.198 0.167 DBMET02858 | DBMET02856 | |
| 0.068 | 0.005 | 0.128 | Estrone sulfatase inhibitor | 0.114 0.004 DB00860 0.048 0.008 DBMET02848 0.085 0.005 DBMET02849 0.085 0.005 DBMET02850 0.079 0.005 DBMET02851 0.079 0.005 DBMET02853 0.128 0.004 DB00635 0.06 0.006 DBMET02852 0.06 0.006 DBMET02854 0.067 0.005 DBMET02856 0.06 0.006 DBMET02857 0.054 0.007 DBMET02859 0.096 0.005 DBMET02860 0.096 0.005 DBMET02861 0.079 0.005 DBMET02863 0.079 0.005 DBMET02864 0.053 0.007 DBMET02855 0.053 0.007 DBMET02858 0.063 0.006 DBMET02862 | DB00635 | |
| 0.089 | 0.029 | 0.099 | Glycine receptor agonist | 0.099 0.022 DB00860 0.078 0.041 DBMET02849 0.078 0.041 DBMET02850 0.067 0.062 DBMET02851 0.067 0.062 DBMET02853 0.083 0.035 DB00635 0.074 0.047 DBMET02856 0.07 0.054 DBMET02860 0.07 0.054 DBMET02861 0.067 0.062 DBMET02863 0.067 0.062 DBMET02864 | DB00860 | |
| 0.091 | 0.035 | 0.105 | T cell inhibitor | 0.105 0.02 DB00860 0.103 0.022 DBMET02848 0.083 0.055 DBMET02849 0.083 0.055 DBMET02850 0.093 0.032 DBMET02851 0.093 0.032 DBMET02853 0.096 0.029 DB00635 0.087 0.043 DBMET02856 0.094 0.032 DBMET02859 0.088 0.042 DBMET02863 0.088 0.042 DBMET02864 | DB00860 | |
| 0.101 | 0.046 | 0.103 | Bile acid receptor antagonist | 0.103 0.043 DB00860 0.096 0.057 DBMET02849 0.096 0.057 DBMET02850 0.092 0.068 DBMET02851 0.092 0.068 DBMET02853 0.102 0.045 DBMET02856 0.095 0.06 DBMET02855 0.095 0.06 DBMET02858 | DB00860 | |
| 0.111 | 0.057 | 0.152 | Expectorant | 0.131 0.044 DB00860 0.152 0.034 DBMET02848 0.089 0.082 DBMET02849 0.089 0.082 DBMET02850 0.132 0.044 DBMET02851 0.132 0.044 DBMET02853 0.09 0.081 DBMET02852 0.09 0.081 DBMET02854 0.136 0.041 DBMET02856 0.09 0.081 DBMET02857 0.088 0.083 DBMET02863 0.088 0.083 DBMET02864 0.093 0.077 DBMET02855 0.093 0.077 DBMET02858 | DBMET02848 | |
| 0.185 | 0.133 | 0.266 | Spasmolytic | 0.209 0.112 DBMET02848 0.191 0.128 DB00635 0.266 0.084 DBMET02859 0.21 0.111 DBMET02860 0.21 0.111 DBMET02861 0.184 0.134 DBMET02863 0.184 0.134 DBMET02864 | DBMET02859 | |
| 0.099 | 0.049 | 0.099 | Thioredoxin inhibitor | |||
| 0.06 | 0.015 | 0.06 | Microtubule stabilization | 0.054 0.022 DB00860 0.05 0.028 DBMET02848 0.053 0.024 DBMET02849 0.053 0.024 DBMET02850 0.053 0.024 DBMET02851 0.053 0.024 DBMET02853 0.052 0.026 DBMET02852 0.052 0.026 DBMET02854 0.059 0.016 DBMET02856 0.052 0.026 DBMET02857 0.042 0.039 DBMET02863 0.042 0.039 DBMET02864 0.057 0.018 DBMET02855 0.057 0.018 DBMET02858 | ||
| 0.109 | 0.066 | 0.138 | Mucolytic | 0.124 0.05 DB00860 0.138 0.04 DBMET02848 0.127 0.048 DBMET02851 0.127 0.048 DBMET02853 0.132 0.044 DBMET02856 0.097 0.082 DBMET02859 0.105 0.071 DBMET02863 0.105 0.071 DBMET02864 | DBMET02848 | |
| 0.087 | 0.047 | 0.104 | Glycine receptor antagonist | 0.104 0.029 DB00860 0.086 0.048 DBMET02849 0.086 0.048 DBMET02850 0.082 0.054 DBMET02851 0.082 0.054 DBMET02853 0.083 0.052 DBMET02856 | DB00860 | |
| 0.122 | 0.087 | 0.126 | Cytokine production inhibitor | 0.126 0.083 DB00860 | DB00860 | |
| 0.11 | 0.079 | 0.123 | Acetylcholine muscarinic antagonist | 0.123 0.064 DB00860 0.11 0.079 DBMET02848 0.102 0.088 DBMET02849 0.102 0.088 DBMET02850 | DB00860 | |
| 0.102 | 0.072 | 0.24 | DNA intercalator | 0.24 0.018 DB00860 0.208 0.024 DBMET02848 0.203 0.025 DBMET02851 0.203 0.025 DBMET02853 0.226 0.02 DB00635 0.202 0.025 DBMET02856 0.195 0.027 DBMET02859 0.187 0.029 DBMET02863 0.187 0.029 DBMET02864 | DB00860 | |
| 0.043 | 0.014 | 0.073 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.062 0.008 DB00860 0.029 0.026 DBMET02848 0.052 0.01 DBMET02849 0.052 0.01 DBMET02850 0.039 0.016 DBMET02851 0.039 0.016 DBMET02853 0.073 0.005 DB00635 0.033 0.022 DBMET02852 0.033 0.022 DBMET02854 0.037 0.017 DBMET02856 0.033 0.022 DBMET02857 0.034 0.02 DBMET02859 0.059 0.008 DBMET02860 0.059 0.008 DBMET02861 0.039 0.016 DBMET02863 0.039 0.016 DBMET02864 0.031 0.023 DBMET02855 0.031 0.023 DBMET02858 0.045 0.013 DBMET02862 | DB00635 | |
| 0.087 | 0.059 | 0.088 | Ornithine decarboxylase inhibitor | 0.088 0.058 DBMET02862 | DBMET02862 | |
| 0.081 | 0.064 | 0.085 | Estrogen-related receptor beta agonist | 0.084 0.056 DB00860 0.079 0.07 DBMET02849 0.079 0.07 DBMET02850 0.085 0.052 DB00635 0.077 0.076 DBMET02859 0.079 0.072 DBMET02860 0.079 0.072 DBMET02861 | DB00635 | |
| 0.18 | 0.168 | 0.18 | Transcription factor STAT inhibitor | |||
| 0.085 | 0.075 | 0.085 | ABCA1 expression enhancer | |||
| 0.055 | 0.045 | 0.065 | Pregnane X receptor antagonist | 0.055 0.046 DB00860 0.057 0.039 DBMET02849 0.057 0.039 DBMET02850 0.056 0.04 DB00635 0.062 0.025 DBMET02856 0.059 0.032 DBMET02860 0.059 0.032 DBMET02861 0.065 0.021 DBMET02855 0.065 0.021 DBMET02858 0.065 0.021 DBMET02862 | DBMET02862 | |
| 0.12 | 0.111 | 0.12 | Thrombolytic | |||
| 0.044 | 0.036 | 0.05 | Potassium channel Kv1.3 blocker | 0.049 0.03 DBMET02848 0.05 0.03 DBMET02859 0.047 0.033 DBMET02862 | DBMET02859 | |
| 0.03 | 0.023 | 0.03 | Elastase 2B inhibitor | |||
| 0.03 | 0.023 | 0.03 | Elastase 3A inhibitor | |||
| 0.03 | 0.023 | 0.03 | Elastase 3B inhibitor | |||
| 0.027 | 0.02 | 0.056 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.049 0.009 DB00860 0.054 0.008 DBMET02848 0.024 0.023 DBMET02849 0.024 0.023 DBMET02850 0.043 0.01 DBMET02851 0.043 0.01 DBMET02853 0.05 0.008 DB00635 0.056 0.007 DBMET02856 0.056 0.007 DBMET02859 0.025 0.022 DBMET02860 0.025 0.022 DBMET02861 0.049 0.009 DBMET02863 0.049 0.009 DBMET02864 0.028 0.019 DBMET02855 0.028 0.019 DBMET02858 0.034 0.014 DBMET02862 | DBMET02859 | |
| 0.088 | 0.081 | 0.123 | Topoisomerase I inhibitor | 0.123 0.054 DB00860 0.108 0.064 DBMET02848 0.098 0.072 DBMET02851 0.098 0.072 DBMET02853 0.107 0.064 DB00635 0.096 0.073 DBMET02856 0.092 0.077 DBMET02859 0.095 0.075 DBMET02863 0.095 0.075 DBMET02864 | DB00860 | |
| 0.013 | 0.008 | 0.017 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.014 0.006 DB00860 0.013 0.006 DBMET02848 0.013 0.007 DBMET02849 0.013 0.007 DBMET02850 0.014 0.006 DBMET02851 0.014 0.006 DBMET02853 0.015 0.005 DB00635 0.013 0.007 DBMET02852 0.013 0.007 DBMET02854 0.016 0.004 DBMET02856 0.013 0.007 DBMET02857 0.014 0.005 DBMET02859 0.014 0.006 DBMET02860 0.014 0.006 DBMET02861 0.014 0.006 DBMET02863 0.014 0.006 DBMET02864 0.016 0.004 DBMET02855 0.016 0.004 DBMET02858 0.017 0.004 DBMET02862 | DBMET02862 | |
| 0.018 | 0.016 | 0.021 | Progesterone receptor B antagonist | 0.019 0.014 DB00860 0.018 0.017 DBMET02849 0.018 0.017 DBMET02850 0.021 0.011 DB00635 0.021 0.011 DBMET02856 0.018 0.015 DBMET02859 0.019 0.015 DBMET02860 0.019 0.015 DBMET02861 0.019 0.014 DBMET02855 0.019 0.014 DBMET02858 0.021 0.011 DBMET02862 | DBMET02862 | |
| 0.015 | 0.014 | 0.025 | Vitamin D receptor agonist | 0.016 0.012 DB00860 0.018 0.009 DBMET02849 0.018 0.009 DBMET02850 0.016 0.012 DBMET02851 0.016 0.012 DBMET02853 0.016 0.013 DB00635 0.018 0.009 DBMET02852 0.018 0.009 DBMET02854 0.019 0.007 DBMET02856 0.018 0.009 DBMET02857 0.018 0.008 DBMET02860 0.018 0.008 DBMET02861 0.019 0.008 DBMET02863 0.019 0.008 DBMET02864 0.022 0.005 DBMET02855 0.022 0.005 DBMET02858 0.025 0.004 DBMET02862 | DBMET02862 | |
| 0.102 | 0.1 | 0.102 | Cyclooxygenase 3 inhibitor | |||
| 0.026 | 0.025 | 0.041 | Hedgehog signaling activator | 0.034 0.007 DB00860 0.026 0.025 DBMET02848 0.032 0.01 DBMET02849 0.032 0.01 DBMET02850 0.032 0.01 DBMET02851 0.032 0.01 DBMET02853 0.03 0.013 DBMET02852 0.03 0.013 DBMET02854 0.041 0.004 DBMET02856 0.03 0.013 DBMET02857 0.028 0.018 DBMET02863 0.028 0.018 DBMET02864 0.038 0.005 DBMET02855 0.038 0.005 DBMET02858 | DBMET02856 | |
| 0.02 | 0.022 | 0.024 | Protein 30S ribosomal subunit inhibitor | 0.023 0.019 DB00860 0.024 0.016 DBMET02849 0.024 0.016 DBMET02850 0.022 0.02 DBMET02851 0.022 0.02 DBMET02853 0.023 0.018 DBMET02852 0.023 0.018 DBMET02854 0.022 0.02 DBMET02856 0.023 0.018 DBMET02857 0.024 0.017 DBMET02855 0.024 0.017 DBMET02858 | DBMET02858 | |
| 0.014 | 0.02 | 0.019 | Telomerase stimulant | 0.017 0.013 DBMET02851 0.017 0.013 DBMET02853 0.019 0.009 DBMET02856 0.017 0.012 DBMET02855 0.017 0.012 DBMET02858 | DBMET02856 | |
| 0.112 | 0.12 | 0.155 | Acetylcholine M1 receptor antagonist | 0.155 0.07 DB00860 0.121 0.107 DBMET02848 0.118 0.111 DBMET02849 0.118 0.111 DBMET02850 | DB00860 | |
| 0.085 | 0.096 | 0.152 | AMP-activated protein kinase stimulant | 0.125 0.045 DB00860 0.096 0.077 DBMET02848 0.152 0.027 DBMET02849 0.152 0.027 DBMET02850 0.1 0.071 DBMET02852 0.1 0.071 DBMET02854 0.11 0.058 DBMET02856 0.1 0.071 DBMET02857 0.138 0.036 DBMET02855 0.138 0.036 DBMET02858 | DBMET02850 | |
| 0.018 | 0.032 | 0.022 | Vitamin D receptor antagonist | 0.021 0.018 DBMET02849 0.021 0.018 DBMET02850 0.021 0.017 DBMET02856 0.022 0.015 DBMET02855 0.022 0.015 DBMET02858 | DBMET02858 | |
| 0.092 | 0.108 | 0.101 | Cholinergic antagonist | 0.101 0.095 DB00860 | DB00860 | |
| 0.059 | 0.08 | 0.101 | CDC25A inhibitor | 0.101 0.027 DBMET02856 0.097 0.029 DBMET02855 0.097 0.029 DBMET02858 | DBMET02856 | |
| 0.088 | 0.111 | 0.098 | Acetylcholine antagonist | 0.098 0.095 DB00860 | DB00860 | |
| 0.071 | 0.094 | 0.079 | Thioredoxin reductase inhibitor | 0.077 0.072 DB00860 0.079 0.064 DBMET02848 0.078 0.069 DBMET02859 | DBMET02848 | |
| 0.041 | 0.064 | 0.094 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.086 0.014 DB00860 0.053 0.038 DBMET02848 0.071 0.021 DBMET02849 0.071 0.021 DBMET02850 0.048 0.046 DBMET02851 0.048 0.046 DBMET02853 0.094 0.012 DB00635 0.058 0.031 DBMET02859 0.076 0.018 DBMET02860 0.076 0.018 DBMET02861 0.048 0.046 DBMET02863 0.048 0.046 DBMET02864 | DB00635 | |
| 0.041 | 0.064 | 0.12 | HIV-1 integrase (Strand Transfer) inhibitor | 0.12 0.017 DBMET02851 0.12 0.017 DBMET02853 0.059 0.042 DBMET02852 0.059 0.042 DBMET02854 0.059 0.042 DBMET02857 0.093 0.025 DBMET02863 0.093 0.025 DBMET02864 | DBMET02853 | |
| 0.014 | 0.039 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.016 DBMET02851 0.018 0.016 DBMET02853 0.018 0.016 DBMET02863 0.018 0.016 DBMET02864 | DBMET02864 | |
| 0.061 | 0.088 | 0.072 | Keratolytic | 0.072 0.061 DB00860 0.071 0.064 DBMET02849 0.071 0.064 DBMET02850 0.071 0.063 DB00635 0.069 0.067 DBMET02860 0.069 0.067 DBMET02861 | DB00860 | |
| 0.027 | 0.057 | 0.114 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.049 0.03 DB00860 0.074 0.017 DBMET02848 0.044 0.035 DBMET02851 0.044 0.035 DBMET02853 0.079 0.016 DB00635 0.067 0.02 DBMET02856 0.114 0.009 DBMET02859 0.044 0.035 DBMET02860 0.044 0.035 DBMET02861 0.067 0.02 DBMET02863 0.067 0.02 DBMET02864 0.071 0.019 DBMET02862 | DBMET02859 | |
| 0.02 | 0.059 | 0.035 | Farnesoid X receptor agonist | 0.035 0.031 DBMET02856 | DBMET02856 | |
| 0.08 | 0.121 | 0.121 | Amylase inhibitor | 0.121 0.08 DB00860 0.103 0.094 DBMET02849 0.103 0.094 DBMET02850 | DB00860 | |
| 0.098 | 0.141 | 0.132 | Neurotrophic factor | 0.118 0.099 DBMET02849 0.118 0.099 DBMET02850 0.123 0.091 DBMET02851 0.123 0.091 DBMET02853 0.132 0.078 DBMET02852 0.132 0.078 DBMET02854 0.132 0.078 DBMET02857 0.117 0.101 DBMET02855 0.117 0.101 DBMET02858 | DBMET02857 | |
| 0.143 | 0.192 | 0.175 | Hypoglycemic | 0.175 0.14 DBMET02849 0.175 0.14 DBMET02850 0.162 0.16 DBMET02855 0.162 0.16 DBMET02858 | DBMET02850 | |
| 0.089 | 0.139 | 0.109 | Interleukin 2 antagonist | 0.109 0.066 DB00860 0.104 0.078 DBMET02848 | DB00860 | |
| 0.024 | 0.075 | 0.043 | GABA uptake inhibitor | 0.043 0.022 DB00635 0.038 0.029 DBMET02859 0.038 0.03 DBMET02862 | DB00635 | |
| 0.121 | 0.181 | 0.185 | Phospholipase C inhibitor | 0.15 0.106 DB00860 0.157 0.094 DBMET02851 0.157 0.094 DBMET02853 0.154 0.097 DB00635 0.162 0.085 DBMET02856 0.137 0.136 DBMET02860 0.137 0.136 DBMET02861 0.185 0.056 DBMET02863 0.185 0.056 DBMET02864 0.138 0.132 DBMET02855 0.138 0.132 DBMET02858 0.159 0.09 DBMET02862 | DBMET02864 | |
| 0.036 | 0.11 | 0.103 | HIV-1 integrase (3'-Processing) inhibitor | 0.103 0.025 DBMET02851 0.103 0.025 DBMET02853 0.09 0.03 DBMET02863 0.09 0.03 DBMET02864 | DBMET02853 | |
| 0.057 | 0.135 | 0.083 | Prolactin inhibitor | 0.083 0.077 DB00635 | DB00635 | |
| 0.135 | 0.241 | 0.239 | Peptidyltransferase inhibitor | 0.18 0.129 DB00860 0.175 0.138 DBMET02848 0.237 0.061 DBMET02849 0.237 0.061 DBMET02850 0.172 0.142 DBMET02851 0.172 0.142 DBMET02853 0.23 0.067 DBMET02852 0.23 0.067 DBMET02854 0.181 0.127 DBMET02856 0.23 0.067 DBMET02857 0.21 0.087 DBMET02860 0.21 0.087 DBMET02861 0.172 0.142 DBMET02863 0.172 0.142 DBMET02864 0.239 0.059 DBMET02855 0.239 0.059 DBMET02858 0.22 0.076 DBMET02862 | DBMET02858 | |
| 0.096 | 0.22 | 0.155 | Pregnane X receptor agonist | 0.138 0.079 DBMET02849 0.138 0.079 DBMET02850 0.136 0.083 DBMET02852 0.136 0.083 DBMET02854 0.134 0.089 DBMET02856 0.136 0.083 DBMET02857 0.132 0.094 DBMET02860 0.132 0.094 DBMET02861 0.151 0.052 DBMET02855 0.151 0.052 DBMET02858 0.155 0.044 DBMET02862 | DBMET02862 | |
| 0.133 | 0.265 | 0.193 | Angiogenesis inhibitor | 0.193 0.178 DBMET02856 | DBMET02856 | |
| 0.044 | 0.181 | 0.079 | GABA A receptor agonist | 0.079 0.064 DB00635 | DB00635 | |
| 0.084 | 0.239 | 0.165 | Interleukin agonist | 0.165 0.153 DBMET02849 0.165 0.153 DBMET02850 | DBMET02850 | |
| 0.047 | 0.205 | 0.126 | Nitric-oxide synthase inhibitor | 0.126 0.034 DB00635 | DB00635 | |
| 0.018 | 0.21 | 0.052 | Alpha-mannosidase inhibitor | 0.05 0.043 DBMET02849 0.05 0.043 DBMET02850 0.052 0.039 DBMET02855 0.052 0.039 DBMET02858 | DBMET02858 | |
| 0.042 | 0.239 | 0.106 | GABA receptor agonist | 0.106 0.07 DB00635 | DB00635 | |
| 0.014 | 0.249 | 0.06 | GABA receptor antagonist | 0.06 0.032 DB00635 | DB00635 | |
| 0.01 | 0.326 | 0.055 | GABA A receptor antagonist | 0.055 0.035 DB00635 | DB00635 | |
| 0.122 | 0.499 | 0.349 | Calcium channel L-type activator | 0.309 0.15 DBMET02849 0.309 0.15 DBMET02850 0.244 0.212 DBMET02852 0.244 0.212 DBMET02854 0.244 0.212 DBMET02857 0.349 0.118 DBMET02860 0.349 0.118 DBMET02861 0.248 0.207 DBMET02855 0.248 0.207 DBMET02858 0.317 0.143 DBMET02862 | DBMET02861 | |
| 0.025 | 0.498 | 0.098 | Hedgehog signaling inhibitor | 0.098 0.067 DBMET02856 0.089 0.087 DBMET02855 0.089 0.087 DBMET02858 | DBMET02856 | |
| 0.035 | 0.518 | 0.085 | Ca(v)3.1 blocker | 0.082 0.055 DB00635 0.085 0.047 DBMET02859 | DBMET02859 | |
| 0.039 | 0.584 | 0.211 | Antiobesity | 0.211 0.196 DBMET02862 | DBMET02862 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |